Finance
Behavioral health providers have been left behind regarding EHRs, says Alisa Chestler, chair of the data protection, privacy and cybersecurity team at Baker Donelson. A new bill will add federal funding to help the sector, but is it enough?
Ryan Helon, VP of investment funds at Rev1 Ventures, discusses how the firm plans to invest $30 million in growing life sciences startups within the central Ohio region. He describes the resources it and its partners provide to companies.
Joaquim Cunha, executive director of Health Cluster Portugal, discusses increasing cooperation and collaboration in innovation between academia, private industry and healthcare stakeholders both internally and externally in Portugal.
Anca del Rio, a Basel health tech arena leader, relays her experience as a judge at the Startup PitchFest at HIMSS23 Europe, and the factors startups need to possess to go to market and scale successfully, including attraction capital.
Filipe Santos Costa, CEO and chairman of Portugal's international trade and investment agency AICEP, discusses trade and investments in healthcare in the country and its work with HIMSS to promote Portuguese healthcare services abroad.
Leaders from both organizations discuss the motivations behind and the goals of Informa Markets' deal to manage the HIMSS Global Health Conference and Exhibition.
Niall O'Connor, chief technology officer at Cohere Health, discusses how AI and machine learning can help streamline the prior authorization process by analyzing the totality of patient information and reducing denials by health plans.
Naomi Fried, founder and CEO of PharmStars, discusses the 13 startups from its spring cohort and its call for applications for its fall 2023 cohort, Digital Innovations in Therapeutic Delivery: Supply Chain to the Patient Interface.
HIMSS23
Sphere Chief Revenue Officer Ryne Natzke and Chief Product Officer John Welch discuss how data helps healthcare organizations assess patients' ability to pay and collect more revenue via payment flexibility.
HIMSS23
Surescripts' focus is on lowering patient costs and improving both quality of care and patient safety, explains CMIO Dr. Andrew Mellin.